Sign In
Buy LGND
$234.40
+1.64 (+0.705%)
At Close: Jun 03, 2026
Merger Arbitrage Mondays - Qiagen Shareholders Want More
08:04am, Monday, 17'th Aug 2020
Merger activity increased significantly last week with eight new deals announced. The acquisition of Principia Biopharma by Sanofi.
Ligand Pharmaceuticals - Still, Many Moving Parts
07:04am, Thursday, 13'th Aug 2020
LIgand Pharmaceuticals is a business with many moving parts. The company sold its royalty cash cow last year, as it spent most of this money on a deal for Pfenex and share buybacks.
(PFNX) Alert: Johnson Fistel Investigates Proposed Sale of Pfenex; Are Shareholders Getting a Fair Deal?
02:32pm, Wednesday, 12'th Aug 2020
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Pfenex Inc. ("Pfenex" or the "Company") (NYSE American: PFNX) breached their fiduciary d
P/E Ratio Insights for Ligand Pharmaceuticals
05:10pm, Tuesday, 11'th Aug 2020
Looking into the current session, Ligand Pharmaceuticals Inc. (NASDAQ: LGND) is trading at $114.70, after a 3.34% decrease. Over the past month, the stock fell by 3.95%, but over the past year, it act
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) * Allovir Inc (NASDAQ: ALVR) * BioLife Solutions Inc (NASDAQ: BLFS) * BioSpecifics Technologies Corp. (NASDAQ: BSTC) (reacted to sec
Pfenex Pops 59% On Ligand $513M Buy-Out Deal; Analyst Sees 93% Upside
10:22am, Tuesday, 11'th Aug 2020
Ligand Pharmaceuticals has entered into an agreement to buy Pfenex in an all-stock deal for a total consideration of $513 million.As part of the deal, Ligand (LGND), a revenue-generating biopharmaceut
PFENEX ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PFNX and Encourages Investors to Contact the Firm
12:00am, Tuesday, 11'th Aug 2020
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of
Ligand to Acquire Pfenex Inc.
09:36pm, Monday, 10'th Aug 2020
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Pfenex Inc. (NYSE American: PFNX) today announced the signing of a definitive agreement for Ligand to acquire all outstanding shares of Pfenex fo
LGND vs. ILMN: Which Stock Should Value Investors Buy Now?
03:40pm, Friday, 07'th Aug 2020
LGND vs. ILMN: Which Stock Is the Better Value Option?
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces CStone Pharmaceuticals ("CStone", HKEX: 2616) recently reported that its OmniAb-derived anti-PD-L1 mAb CS1001 combined with platinum-based
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces CStone Pharmaceuticals (“CStone”, HKEX: 2616) recently reported that its OmniAb-derived a
Ligand (LGND) Beats on Q2 Earnings & Sales, Raises View
03:01pm, Tuesday, 04'th Aug 2020
Ligand (LGND) reports better-than-expected second-quarter 2020 earnings and revenues. Stock up.
Ligand Trounces Q2 Estimates by Helping Companies Make COVID-19 Drug Remdesivir
06:10pm, Monday, 03'rd Aug 2020
Ligand Pharmaceuticals' (NASDAQ: LGND) big slide in March was only short-lived. Its shares have rebounded nicely over the last several months and came into this week up 12% year to date. The biotech a
Ligand Pharmaceuticals Inc (LGND) Q2 2020 Earnings Call Transcript
06:00pm, Monday, 03'rd Aug 2020
LGND earnings call for the period ending June 30, 2020.
Ligand Pharmaceuticals (LGND) Q2 Earnings and Revenues Beat Estimates
12:55pm, Monday, 03'rd Aug 2020
Ligand (LGND) delivered earnings and revenue surprises of 53.85% and 46.78%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
